Biography
Dr Fiona Kyle is a highly qualified Consultant Medical Oncologist and brings over a decade of consultant-level expertise to the multidisciplinary team. Committed to delivering compassionate, personalised, and patient-centred care, Dr Kyle ensures that every individual is fully supported and empowered throughout their treatment journey.
Dr Kyle trained at University College London before embarking on specialist clinical training across Guy's and St Thomas' and St George's Hospitals. Driven by a passion for advancing cancer outcomes, she earned a PhD in Endocrine Resistance in Breast Cancer from Imperial College London. Since 2015, she has served as a Consultant Medical Oncologist at St George's Hospital.
At Icon Cancer Centre London, Dr Kyle works closely within a comprehensive multidisciplinary team to deliver cutting-edge, evidence-based systemic anti-cancer treatment. She believes in a patient centred approach, taking the time to listen to each patient's concerns, clearly explaining diagnoses and treatment pathways so they can make informed choices about their cancer journey.
Other posts held
St Georges University Hospital
GMC: 06028734
Publications
Kyle F, Spicer J. Targeted therapies in non-small cell lung cancer. Cancer Imaging. 2008 Nov 25;8(1):199-205. doi: 10.1102/1470-7330.2008.0027. PMID: 19028612; PMCID: PMC2590876.
Hill M, Kyle F. NHL (diffuse large B-cell lymphoma). BMJ Clin Evid. 2010 Nov 15;2010:2401. PMID: 21406125; PMCID: PMC3217796.
Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA, Barry S, Crnogorac-Jurcevic T, Martin LA, Dowsett M, Charles Coombes R, Kamalati T, Ali S, Buluwela L. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Res Treat. 2011 Jul;128(2):357-68. doi: 10.1007/s10549-010-1122-6. Epub 2010 Aug 22. PMID: 20730598.
Rey J, Hu H, Kyle F, Lai CF, Buluwela L, Coombes RC, Ortlund EA, Ali S, Snyder JP, Barrett AG. Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation. ChemMedChem. 2012 Nov;7(11):1909-14. doi: 10.1002/cmdc.201200307. Epub 2012 Sep 7. PMID: 22961990.
Thiruchelvam, Paul T. R., Lai, Chun-Fui, Hua, Hui, Thomas, Ross S., Hurtado, Antoni, Hudson, William, Bayly, Andrew R., Kyle, Fiona J., Periyasamy, Manikandan, Photiou, Andrew, Spivey, Alan C., Ortlund, Eric A., Whitby, Richard J., Carroll, Jason S., Coombes, R. Charles, Buluwela, Laki and Ali, Simak (2010) The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Research and Treatment. (doi:10.1007/s10549-010-0994-9). (PMID:20607599)